Mark Cuban partners with Fedegari on disruptive drug manufacturing

摘要

Fedegari has been selected to partner with Mark Cuban Cost Plus Drug Company (MCCPDC) on supplying washing and sterilisation equipment to its new facility in Dallas, Texas. The 22,000 sqft sterile fill-finish site will manufacture and provide low-cost versions of high-cost generic drugs using Fedegari's innovative design which combines the washing and sterilisation process into one unit.